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Abstract – This paper presents a novel wearable sensor 
system based on the integration of miniaturised IMUs 
for fine hand movement analysis. The system, named 
SensHand V1, is composed of full 9-axis inertial 
sensors, placed on the fingers and wrist, which are 
managed by a cortex-M3 microcontroller. The 
acquired data are sent to a data logger through the 
use of Bluetooth communication. In this paper, the 
system is used for the objective diagnosis of 
Parkinson's disease, which is commonly assessed by 
neurologists through visual examination of motor 
tasks and semi-quantitative rating scales. Here, these 
motor tasks are also assessed using the SensHand V1, 
and then compared with the subjective metrics. 
Results demonstrate that the system is adequate to 
support neurologists in diagnostic procedures and 
allows for an objective evaluation of the disease. 
 I. INTRODUCTION 
Parkinson's disease (PD) is the second most common 
neurodegenerative disorder. It presents with characteristic 
and disabling motor symptoms, such as tremors, 
muscular rigidity, postural instability, bradykinesia and 
hypokinesia, caused by a loss of brain dopaminergic 
neurons. Approximately one million Americans and more 
than 1.2 million Europeans [1] suffer from it, with this 
number forecasted to double by 2030 [2]. Parkinson’s has 
an estimated annual cost for the European community of 
about 13.9 billion euro [1]. 
Currently, for the assessment of movement disorders, the 
neurologist uses a visual examination of motor tasks and 
semi-quantitative rating scales, such as the Hoehn-Yahr 
(HY) Scale [3] and the Movement Disorder Society - 
Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS) [4]. Previous studies [5–6] demonstrated a five 
years latency time between the beginning of the process 
and the appearance of the typical symptoms of PD, which 
is diagnosed when the neurodegenerative process has yet 
compromised wide brain areas. Moreover, the best 
objective testing for PD consists of specific brain 
scanning techniques (e.g. SPECT DATSCAN) that can 
measure the dopamine system and brain metabolism. 
However, these examinations are invasive, very 
expensive and require specialised imaging centres and 
specially trained and dedicated staff. 
The opportunity to objectify and to hasten the diagnostic 
process could be a major milestone in the management of 
the disease: 1) minimising both intra-rater and inter-rater 
variability due to neurologist subjectivity; 2) slowing 
down the disease progression, with a greater effectiveness 
in addressing the biochemical imbalance that determines 
the illness and its worsening [7]; 3) reducing the 
economic impact of the disease; and 4) favouring a better 
Quality of Life (QoL) for patients for longer period of 
time. 
The system proposed in the paper, called SensHand V1, 
provides an objective and quantitative analysis of the 
movements of the upper limbs through an inertial 
measurement unit (IMU) which is low-cost, low-power, 
non-invasive, small in size, lightweight, wireless and easy 
to use. Such a system can be used to support early clinical 
diagnosis, as well as to periodically monitor patients’ 
motor performances over time, providing detailed 
information for each patient about disease course and 
therapy effectiveness. 
Prototypes and commercial products based on wearable 
devices are mainly glove-shaped [8–9], developed to 
faithfully reproduce the movement of the hand and are 
generally based on flex sensors [10], inertial sensors [11–
13] or their combination. Applications vary from virtual 
reality management to biomedical applications, including 
the study of PD and assistance for patients with 
movement disorders [14]. However, the proposed 
solutions show limitations, especially in size, wearability, 
modularity and adaptability. The technological 
advantages of the SensHand V1 [15–16] can be 
synthesised in the following properties. 
•Physical properties: 1) miniaturisation, integration and 
20th IMEKO TC4 International Symposium and 
18th International Workshop on ADC Modelling and Testing 
Research on Electric and Electronic Measurement for the Economic Upturn 
Benevento, Italy, September 15-17, 2014 
 
reduced weight for full wearability; 2) independence from 
the physical constitution of the subject wearing it; 3) 
independence of artefacts caused by the movement; 4) 
wireless communication. 
•Properties of measurement: 1) a complete inertial 
system; 2) repeatability and endurance of the sensors not 
affected by deterioration problems or drift conditions; 3) 
infrequent calibration required thanks to an intrinsic 
compensation typical of 3-axial systems. 
•Additional properties: low-cost components, low-power 
consumption. 
 II. INSTRUMENTS 
The SensHand V1 wearable device (Fig. 1) was 
developed using inertial sensors (gyroscopes and 
accelerometers) integrated into four INEMO-M1 boards 
(size: 4x5x1.1 mm), based on MEMS sensors and 
equipped with dedicated STM32F103RE 
microcontrollers (ARM 32-bit Cortex™-M3 CPU, 
STMicroelectronics, Italy). 
 
Fig. 1. SensHand V1 wearable device. 
 
Each module includes LSM303DLHC (6-axis 
geomagnetic module, dynamically user-selectable full 
scale acceleration range of ±2 g/±4 g/±8 g/±16 g and a 
magnetic field full-scale of ±1.3÷±8.1 gauss) and 
L3G4200D (3-axis digital gyroscope, user-selectable 
angular rate full-scale of ±250/±500/±2000 deg/s), I2C 
digital output. As a result, each board is able to measure 
metrics and parameters related to the human hand by 
means of the complete 9-axis sensor system on board, 
guaranteeing a three-dimensional mapping of motion. 
Module coordination and data synchronisation are 
implemented through the Controller Area Network 
(CAN) standard. The module, placed on the forearm, is 
the coordinator of the system, collecting data at frequency 
of 100 Hz (fs) and transmitting them towards a generic 
control station through a wireless communication based 
on the ESD 210 (Parani) Bluetooth serial device. The 
other modules are positioned on the distal phalanges of 
the thumb, index and middle fingers. A small, 
rechargeable and light polymer lithium battery, integrated 
into the coordinator module, supplies the system. 
 
 
 
 A. Sensor Unit Calibration 
The sensor unit is adequately calibrated, both in static and 
dynamic states, in order to calculate the offset and 
sensitivity that affect measurements and correct them. For 
gyroscope calibration, output mean value ωi is calculated 
in static conditions and represents the gyroscope offsets 
on i-axis (O_ωi). Calibrated data from the gyroscopes are 
computed as follows: 
           (i = x, y, z)  (1) 
Calibration of the accelerometers requires two static 
acquisitions in order to calculate the sensor’s sensitivity 
and three static ones in order to define the offset for each 
axis. Sensitivity Sva for each i-axis is defined as: 
     
                 
 
           (2) 
where max(ai) is the maximum value of ai at the ‘1g’ 
condition (‘g’ is acceleration due to gravity), while 
min(ai) is the minimum value of ai at ‘-1g’ condition. To 
calculate the offset for i-axis (O_ai), the mean value of ai 
output was calculated with i-axis at ‘0g’ condition. 
Finally, the calibrated data from the accelerometers are 
calculated as follows: 
                       (3) 
 III. METHODOLOGY 
A preliminary experimentation at the Neurology 
Operative Unit of Carrara Hospital was conducted to 
show the feasibility and scientific/technical effectiveness 
of the proposed system in distinguishing PD patients 
from healthy subjects, and supporting the diagnosis of 
Parkinson's disease. 
 A. Participants 
Fifteen patients with a diagnosis of PD (nine male and six 
female, mean age ± SD: 69.4 ± 4.5 years) and six healthy 
controls (HC) (two male and four female, mean age ± 
SD: 63.3 ± 8.2 years,) were included in the study. All 
patients were on medication before and during the 
experiments. Exclusion criteria included impairments or 
diseases other than PD that could affect the performance 
of daily activities. The study procedures received the 
approval of the ASL1 Massa and Carrara Ethics 
Committee (n°1148/ 12.10.10). 
 B. Clinical Assessment 
Patients attending the study were first evaluated by a 
neurologist by means of clinical scales typically used for 
PD assessment as reported in Table 1. 
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Table 1. Scores assigned to PD patients in relation to the 
clinical evaluation scales 
Clinical Features  
of PD Patients 
Mean±SD N° 
–Disease stage (HY): 2.6±1.0 15 
Very early (HY 1)  3 
Early (HY 2)  2 
Moderate (HY 3)  8 
Advanced (HY 4)  2 
–Activity limitation (S&E%) [17] 76.0±18.1 15 
–Disease severity: UPDRS (total) 37.9±18.7 15 
MDS-UPDRS III (Motor Section) 19.2±10.9 15 
 C. Experimental Protocol 
According to the neurologist and to the motor section of 
the MDS-UPDRS, an experimental protocol comprised of 
three exercises (performed three times, both hands), such 
Thumb-Forefinger Tapping (THFF), Forearm 
Pronation/Supination (PSUP) and Hand 
Opening/Closing (OPCL), has been proposed to analyse 
the motor skills of the upper limbs of the subjects in this 
study. In addition, every subject attended a short 
preliminary training to try all of the required movements. 
 D. Exercises Description 
During the trial session, subjects assumed a comfortable 
and standardised sitting posture. For each exercise, an 
initial specific fixed position was established to permit a 
static acquisition in order to calibrate each trial. The 
exercises had to be performed for 10 seconds, as quickly 
and widely as possible. The descriptions of the exercises 
are as follows: 
THFF: The subject was directed to keep the hand fixed 
on the desk, so that the plane between the thumb and 
forefinger joined together was parallel to the table. In the 
starting position, the thumb and the forefinger were in 
contact, and then the subject tapped the forefinger against 
the thumb. 
PSUP: The subject was asked to put his sensorised arm 
outstretched in front of him/herself, with the wrist stable 
and the hand in prone position. The prono/supinations 
had to be performed in parallel to the floor. 
OPCL: The subject was directed to flex the arm that was 
fixed on the table at the elbow, keeping the palm of the 
hand in front of him/herself. The subject had to 
alternatively open and close his/her sensorised hand, 
holding the forearm and the wrist fixed. 
 E. Extracted Features 
For exercises performed by subjects using the SensHand 
V1, some biomechanical parameters, such as frequency, 
amplitude and velocity were measured (Table 2). 
 
 
 
 
Table 2. Extracted biomechanical features 
Ex. Biomechanical Features 
THFF 
–Number of taps and frequency (taps/s) 
–Amplitude (deg) of index finger movement 
–Opening and closing velocity (deg/s) of the 
forefinger 
–Energy expenditure 
PSUP 
–Number of rotations and frequency 
(rotations/s) 
–Amplitude (deg) of the movement 
–Velocity (deg/s) in supination and pronation 
movements 
–Energy expenditure 
OPCL 
–Number of movements and frequency 
(movements/s) 
–Amplitude (deg) of the movement 
–Opening and closing hand velocity (deg/s) 
–Energy expenditure 
The tasks proposed by the MDS-UPDRS can thus be 
evaluated in an objective way by means of the assessment 
of these features, overcoming the issues related to the 
subjectivity of medical judgment. 
 IV. DATA PROCESSING 
The inertial data acquired with the SensHand V1 were 
stored on the PC and processed offline using Matlab®. All 
of the measured parameters were obtained from the 
acceleration and angular rate data supplied by the 
accelerometers and gyroscopes. A fourth-order low-pass 
digital Butterworth filter was applied with a 5 Hz cut-off 
frequency (fc) in order to eliminate high-frequency noise 
and tremor frequency bands. In the analysis conducted in 
the spatio-temporal domain, the appropriate algorithms of 
segmentation were implemented in order to identify the 
characteristic times of the typical phases for each 
exercise. Angular rates were integrated using the 
trapezoidal rule, with sub-intervals of integration equal to 
the inverse of the sensor-sampling rate (∆t=100 ms), in 
order to calculate the movement amplitude. For finger 
tapping exercises, it was hypothesised that movement 
occurred only at the metacarpo-phalangeal joint and that 
the finger was a rigid segment. 
 A. Events Detection 
The function to gather information about the different 
phases in all exercises was performed by the gyroscope 
signal of the axis orthogonal to the plane of the 
movement. The segmentation procedure used threshold 
algorithms that divided acquired signals into some 
phases, depending on the complexity of each exercise. It 
was assumed that the initial condition for the angle was 
null (θinit=0). To improve the accuracy of the measures, a 
nulling algorithm was applied to the gyroscope signal: it 
provided the offset reckoning, averaging the angular 
velocity from N gyroscope samples (N=100) collected in 
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the static phase: 
      
 
 
       
 
             (4) 
For the movement exercises, θ angles covered during the 
movements were calculated. The outcome measures of 
the performances were computed from the angular rate 
and from the amplitude calculated through the integration 
of it and representing the θ angles covered during the 
movements. To remove sensor drift in the analysis of 
data, the "Zero Velocity Update" technique [18] was 
applied to remove cumulative effects in order to obtain 
accurate integration results. 
Examples of events detection and signal processing are 
reported in Figure 2, where angular velocity and angular 
displacement of the forefinger in the THFF for both a PD 
patient and a healthy control are represented. The control 
subject clearly shows higher frequency, velocity and 
amplitude of movement than does the PD patient. 
 
 
Fig. 2. A signal-processing example: thumb-forefinger 
tapping for a PD patient (top) and for a healthy control 
(bottom). Angular velocity (blue), angular displacement 
(black) and characteristic times (Tstart in green, TTF in 
cyan and Tend in red) are represented. Tstart is the time that 
the movement starts; TTF is the time in which the thumb 
and the forefinger are at the maximum distance, Tend is 
the time that the movement ends and the thumb and the 
forefinger are in contact again. 
 
 
 V. RESULTS AND DISCUSSIONS 
 A. Biomechanical Assessment 
A statistical analysis was conducted of the biomechanical 
features that were extracted. An univariate ANOVA 
analysis (p-value<0.01), combined with a further 
comparative analysis (Pearson’s correlation coefficient) 
permitted only four parameters to be selected in order to 
distinguish the group of PD patients from the healthy 
controls (Fig. 3).  
 
Fig. 3: Results regarding the motor performances of the 
two examined groups were summarised through the 
principal component analysis (PCA). 
The four resulting parameters that best described the 
existing differences between the two examined groups 
were: number of pronosupination (num_PS), pronation 
velocity (ω_sp), number of hand opening/closing 
movements (num_OC) and energy expenditure 
(IAV_OC). The mean values and standard deviations for 
these parameters are reported in Table 3 for both the right 
hand (RH) and the left hand (LH). 
Table 3. Mean values and standard deviations of 
significant parameters. 
Parameter PD (mean±SD) HC (mean±SD) 
num_PS_RH 11.4±4.1 22.8±11.4 
num_PS_LH 11.5±6.3 23.8±10.1 
ω_sp_RH 276.6±98.0 477.7±188.8 
ω_sp_LH 254.2±130.8 499.8±106.0 
num_OC_RH 16.0±5.4 33.4±5.5 
num_OC_LH 15.1±7.3 35.4±4.4 
IAV_OC_RH 124.3±21.5 233.9±68.6 
IAV_OC_LH 137.8±45.2 287.9±59.7 
 B. Correlation to Clinical Assessment 
The statistical correlation between the clinical scores that 
were subjectively assigned to PD patients by the 
neurologist and the quantitative outcome measures 
obtained from the patients’ motor performances was 
evaluated through the use of a multiple linear regression, 
20th IMEKO TC4 International Symposium and 
18th International Workshop on ADC Modelling and Testing 
Research on Electric and Electronic Measurement for the Economic Upturn 
Benevento, Italy, September 15-17, 2014 
 
as reported in Table 4. The multiple R was high for all of 
the scales, ranging between 0.86 to 0.95, meaning that the 
system is able to assess patients with Parkinson's disease 
in the various stages of development. 
Table 4. Correlation to clinical scales. 
Clinical Scales Multiple R 
MDS-UPDRS III 0.87 
MDS-UPDRS I-IV 0.95 
HY 0.92 
Schwab & England 0.86 
 VI. CONCLUSIONS 
This work demonstrates the technical effectiveness of a 
wearable sensor system for hand fine motor skills 
analysis and its usefulness in the assessment of objective 
metrics in the diagnostic procedures for PD, as 
demonstrated by the preliminary experimentation. More 
complete protocols to assess the subjects’ motor 
performances can support a PD diagnosis with increasing 
accuracy in the early stages of pathology. The SensHand 
V1 device opens several possibilities in the applications 
of future customised healthcare programmes, not only in 
healthcare facilities, but also in domestic environments. 
Indeed, being easy to use, low-cost, and easily 
connectable in cloud platform, it is particularly adequate 
for empowering patients to manage their diseases, and 
thus allows professionals and patients to design new 
personalised healthcare services in the patient’s home. 
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